Target ROCK therapy (Avicenna)

N/A

Report date: 2024/09/13 11:44:41

Base Information

Drug NameTarget ROCK therapy (Avicenna)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsPolycystic Kidney DiseasesDiabetic NephropathiesAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvicenna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvicenna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney DiseasesDiabetic NephropathiesAmyotrophic Lateral Sclerosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A